Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice

Pharmacological Research

Volumn 53, Issue 3, 2006, Pages 202-208

  Cheng, Hong ^a   Xia, Bing ^a   Zhang, Lin ^a   Zhou, Feng ^a   Zhang, Yu Xia ^a   Ye, Mei ^a   Hu, Zheng Guo ^a   Li, Jin ^a   Li, Jiang ^a   Wang, Zhong Li ^a   Li, Chun ^a   Guo, Qiu Sha ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Colitis; Matrine; Mice; Trinitrobenzene sulfonic acid; Tumour necrosis factor

Indexed keywords

MATRINE; MESSENGER RNA; MYELOPEROXIDASE; SODIUM CHLORIDE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; HISTOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION; WEIGHT REDUCTION;

ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; COLITIS; COLON; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; NEUTROPHILS; PEROXIDASE; QUINOLIZINES; RNA, MESSENGER; TIME FACTORS; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 32644470998     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.11.001     Document Type: Article

References (35)

1. D.K. Podolsky Inflammatory bowel disease (1) N Engl J Med 325 1991 928 937
2. D.K. Podolsky Inflammatory bowel disease (2) N Engl J Med 325 1991 1008 1016
3. C. Fiocchi Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 1998 182 205
4. P. Parronchi, P. Romagnani, F. Annunziato, S. Sampognaro, A. Becchio, and L. Giannarini Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease Am J Pathol 150 1997 823 832
5. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J Exp Med 182 1995 1281 1290
6. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
7. I.J. Fuss, T. Marth, M.F. Neurath, G.R. Pearlstein, A. Jain, and W. Strober Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice Gastroenterology 117 1999 1078 1088
8. L. Baidoo, and G.R. Lichtenstein What next after infliximab? Am J Gastroenterol 100 2005 80 83
9. F. Rizzello, P. Gionchetti, A. Venturi, C. Morselli, and M. Campieri Review article: the management of refractory Crohn's disease Aliment Pharmacol Ther 16 Suppl. 4 2002 40 47
10. G.R. Lichtenstein Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease Inflamm Bowel Dis 7 Suppl. 1 2001 S23 S29
11. A. Lapidus, O. Bernell, G. Hellers, and R. Lofberg Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients Gastroenterology 114 1998 1151 1160
12. Z.L. Hu, J.P. Zhang, D.H. Qian, W. Lin, W.F. Xie, and X.R. Zhang Effects of matrine on mouse splenocyte proliferation and release of interleukin-1 and -6 from peritoneal macrophages in vitro Zhongguo Yao Li Xue Bao 17 1996 259 261
13. M.S. Chang, J.G. Xiao, and G.C. Chiou Prevention of ocular inflammation by matrine, prednisolone, and cyclooxygenase and lipoxygenase inhibitors Zhongguo Yao Li Xue Bao 12 1991 121 125
14. H.R. Tan, and B.H. Zhang Experimental study of the anti-inflammatory effect of matrine Zhong Xi Yi Jie He Za Zhi 5 1985 108 109
15. Y.X. Luo, X.M. Zhang, W. Gao, and Q.F. Wu Studies on site of analgesic action of matrine and its mechanism Zhong Cao Yao 32 2001 41 43
16. C.Q. Xu, D.L. Dong, Z.M. Du, Q.W. Chen, D.M. Gong, and B.F. Yang Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866 Yao Xue Xue Bao 39 2004 691 694
17. B.H. Zhang, N.S. Wang, X.J. Li, X.J. Kong, and Y.L. Cai Anti-arrhythmic effects of matrine Zhongguo Yao Li Xue Bao 11 1990 253 257
18. H. Deng, H. Luo, F. Huang, X. Li, and Q. Gao Inhibition of proliferation and influence of proto-oncogenes expression by matrine in C6 cell Zhong Yao Cai 27 2004 416 419
19. Y.Q. Zhang, G.S. Huang, Z. Wang, Y. Guo, and H.Y. Zhang Effects of matrine on the relative molecules expression of proliferation and apoptosis in K562 cells Zhongguo Yi Xue Ke Xue Yuan Xue Bao 23 2001 333 336
20. J.P. Zhang, M. Zhang, C. Jin, B. Zhou, W.F. Xie, and C. Guo Matrine inhibits production and actions of fibrogenic cytokines released by mouse peritoneal macrophages Acta Pharmacol Sin 22 2001 765 768
21. S.M. Xin, and Z.Q. Ma Anti-diarrhea effect of matrine Zhong Cheng Yao 20 1998 30 32
22. R.J. Pei, L. Xiao, X.P. Fan, and X.J. Liu The effects of matrine on mouse immune functions Hai Xia Yao Xue 10 1998 7 8
23. J.L. Wallace, and C.M. Keenan An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis Am J Physiol 258 1990 G527 G534
24. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 1982 206 209
25. L.J. Murray, R. Lee, and C. Martens In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse Eur J Immunol 20 1990 163 170
26. X. Guo, W.P. Wang, J.K. Ko, and C.H. Cho Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats Gastroenterology 117 1999 884 892
27. M.J. Palmen, C.D. Dijkstra, M.B. van der Ende, A.S. Pena, and E.P. van Rees Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats Clin Exp Immunol 101 1995 351 356
28. G.A. Castro Myeloperoxidase and intestinal inflammation Gastroenterology 88 1985 1294 1295
29. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
30. D.H. Present, P. Rutgeerts, S. Targan, S.B. Hanauer, L. Mayer, and R.A. Van Hogezand Infliximab for the treatment of fistulas in patients with Crohn's disease N Engl J Med 340 1999 1398 1405
31. G. D'Haens, S. Van Deventer, R. Van Hogezand, D. Chalmers, C. Kothe, and F. Baert Endoscopic and histological healing with infliximab anti-tumour necrosis factor antibodies in Crohn's disease: a European multicenter trial Gastroenterology 116 1999 1029 1034
32. P. Rutgeerts, G. D'Haens, S. Targan, E. Vasiliauskas, S.B. Hanauer, and D.H. Present Efficacy and safety of retreatment with anti-tumour necrosis factor antibody (infliximab) to maintain remission in Crohn's disease Gastroenterology 117 1999 761 769
33. W.J. Sandborn, B.G. Feagan, S.B. Hanauer, D.H. Present, L.R. Sutherland, and M.A. Kamm An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial Gastroenterology 120 2001 1330 1338
34. S.J. Van Deventer Tumour necrosis factor and Crohn's disease Gut 40 1997 443 448
35. Z.L. Hu, J.P. Zhang, M.B. Wan, X.B. Yu, W. Lin, and D.H. Qian Effect of matrine on mouse hepatitis and tumour necrosis factor production induced by Propionibacterium acnes/lipopolysaccharides Yao Xue Xue Bao 31 1996 662 665